MedCap AB Statistics

Total Valuation

MedCap AB has a market cap or net worth of SEK 7.19 billion. The enterprise value is 7.30 billion.

Market Cap	7.19B
Enterprise Value	7.30B

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	n/a

Share Statistics

MedCap AB has 14.81 million shares outstanding. The number of shares has increased by 0.47% in one year.

Shares Outstanding	14.81M
Shares Change (YoY)	+0.47%
Shares Change (QoQ)	+0.25%
Owned by Insiders (%)	4.12%
Owned by Institutions (%)	59.27%
Float	11.23M

Valuation Ratios

The trailing PE ratio is 33.71.

PE Ratio	33.71
Forward PE	n/a
PS Ratio	4.10
PB Ratio	6.26
P/FCF Ratio	27.38
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.77, with an EV/FCF ratio of 27.79.

EV / Earnings	34.18
EV / Sales	4.16
EV / EBITDA	19.77
EV / EBIT	26.59
EV / FCF	27.79

Financial Position

The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.32.

Current Ratio	2.39
Quick Ratio	1.62
Debt / Equity	0.32
Debt / EBITDA	0.99
Debt / FCF	1.40
Interest Coverage	15.87

Financial Efficiency

Return on equity (ROE) is 20.37% and return on invested capital (ROIC) is 12.40%.

Return on Equity (ROE)	20.37%
Return on Assets (ROA)	9.99%
Return on Capital (ROIC)	12.40%
Revenue Per Employee	3.31M
Profits Per Employee	402,830
Employee Count	514
Asset Turnover	1.02
Inventory Turnover	2.72

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +80.48% in the last 52 weeks. The beta is 0.72, so MedCap AB's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	+80.48%
50-Day Moving Average	518.91
200-Day Moving Average	456.33
Relative Strength Index (RSI)	41.55
Average Volume (20 Days)	12,978

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedCap AB had revenue of SEK 1.75 billion and earned 213.50 million in profits. Earnings per share was 14.40.

Revenue	1.75B
Gross Profit	1.04B
Operating Income	274.50M
Pretax Income	273.40M
Net Income	213.50M
EBITDA	331.70M
EBIT	274.50M
Earnings Per Share (EPS)	14.40

Full Income Statement

Balance Sheet

The company has 262.80 million in cash and 367.00 million in debt, giving a net cash position of -104.20 million or -7.04 per share.

Cash & Cash Equivalents	262.80M
Total Debt	367.00M
Net Cash	-104.20M
Net Cash Per Share	-7.04
Equity (Book Value)	1.15B
Book Value Per Share	77.50
Working Capital	499.10M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 299.10 million and capital expenditures -36.50 million, giving a free cash flow of 262.60 million.

Operating Cash Flow	299.10M
Capital Expenditures	-36.50M
Free Cash Flow	262.60M
FCF Per Share	17.73

Full Cash Flow Statement

Margins

Gross margin is 59.55%, with operating and profit margins of 15.66% and 12.18%.

Gross Margin	59.55%
Operating Margin	15.66%
Pretax Margin	15.60%
Profit Margin	12.18%
EBITDA Margin	18.92%
EBIT Margin	15.66%
FCF Margin	14.98%

Dividends & Yields

MedCap AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.47%
Shareholder Yield	-0.47%
Earnings Yield	2.97%
FCF Yield	3.65%

Stock Splits

The last stock split was on September 27, 2016. It was a reverse split with a ratio of 0.1.

Last Split Date	Sep 27, 2016
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a